1.880
1.88 (0%)
As of Dec 20, 2024
Intensity Therapeutics, Inc [INTS]
Source:
Company Overview
Intensity Therapeutics, Inc. is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction leading to anti-cancer immune activation. Our new approach involves the direct injection into tumors of a unique product created from our DfuseRxSM discovery platform.
Country | United States |
Headquarters | shelton, connecticut |
Phone Number | ( 203 ) 221-7381 |
Industry | manufacturing |
CEO | Lewis H. Bender |
Website | www.intensitytherapeutics.com |